396 related articles for article (PubMed ID: 26116372)
1. MiR-21: an environmental driver of malignant melanoma?
Melnik BC
J Transl Med; 2015 Jun; 13():202. PubMed ID: 26116372
[TBL] [Abstract][Full Text] [Related]
2. Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
Mishra PJ; Mishra PJ; Merlino G
PLoS One; 2016; 11(11):e0165102. PubMed ID: 27846237
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors.
Melnik BC; John SM; Carrera-Bastos P; Schmitz G
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751207
[TBL] [Abstract][Full Text] [Related]
5. MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
Ren JW; Li ZJ; Tu C
Int J Clin Exp Pathol; 2015; 8(6):6356-66. PubMed ID: 26261511
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
Jiao J; Fan Y; Zhang Y
J Int Med Res; 2015 Oct; 43(5):672-8. PubMed ID: 26150475
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in melanoma biology.
Kunz M
Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
11. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma.
Felicetti F; De Feo A; Coscia C; Puglisi R; Pedini F; Pasquini L; Bellenghi M; Errico MC; Pagani E; Carè A
J Transl Med; 2016 Feb; 14():56. PubMed ID: 26912358
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
Li L; Zhou L; Li Y; Lin S; Tomuleasa C
J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949
[TBL] [Abstract][Full Text] [Related]
17. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
19. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.
Li B; Ren S; Li X; Wang Y; Garfield D; Zhou S; Chen X; Su C; Chen M; Kuang P; Gao G; He Y; Fan L; Fei K; Zhou C; Schmit-Bindert G
Lung Cancer; 2014 Feb; 83(2):146-53. PubMed ID: 24331411
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
